A Follow-Up Study on the Renal Protective Efficacy of Telbivudine for Hepatitis B Virus-Infected Taiwanese Patients After Living Donor Liver Transplant.

@article{Lin2017AFS,
  title={A Follow-Up Study on the Renal Protective Efficacy of Telbivudine for Hepatitis B Virus-Infected Taiwanese Patients After Living Donor Liver Transplant.},
  author={Kuo-Hua Lin and Yao-Li Chen and Ping-Yi Lin and Chia-En Hsieh and Chih-Jan Ko and Chia-Cheng Lin and Ying-zi Ming},
  journal={Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation},
  year={2017},
  volume={15 1},
  pages={65-68}
}
OBJECTIVES Preservation of renal function is an important issue after living donor liver transplant. We aimed to examine the renal protective efficacy of telbivudine in hepatitis B virus-infected patients after living donor liver transplant. MATERIALS AND METHODS In this retrospective study, we compared 18 patients who received telbivudine 600 mg once per day and 23 patients who received entecavir 1 mg once per day after living donor liver transplant. Clinical data were obtained through chart… CONTINUE READING